Hans Tai
President @ ITIC: Industrial Technology Investment Corporation
Hans Tai is a funding round investor at ITIC: Industrial Technology Investment Corporation focused on Medical and Marketing. Mr. Hans Tai serves as President at Industrial Technology Investment Corporation. From 2014 to 2017, Mr. Tai served as Chairman at Cuiqin Communication Co., Ltd. From 2012 to 2017, he served as Chairman at Xinqiao Lianhe Venture Capital Co., Ltd. From 2010 to 2013, Mr. Tai served as Chairman at the Shanghai Office, Youyoucun Network Co., Ltd. From2010 to 2017, he served as General Manager at InnoBridge International Inc. From 2000 to 2009, Mr.Tai served as Investment Officer at Lingyang Technology Co., Ltd. and General Manager at Lingyang Venture Capital Co., Ltd. From 1997 to 2010, he served as Fund Manager at Debang Venture Capital Co., Ltd. Mr. Tai obtained his Master's in Engineering from University of Toronto in 1996. He obtained his Bachelor's degree from National Chiao Tung University in 1992.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Hans Tai invests in
Stages Hans Tai invests in
Countries Hans Tai invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (25%)
- Marketing 1 (25%)
- Industrial 1 (25%)
- Health Care 1 (25%)
- Biotechnology 1 (25%)
Stage
- Funding Round 2 (50%)
- Series A 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- Japan 1 (25%)
- United States 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cellusion
|
Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system. | $15.6M / May 31, 2020 | |
|
Cellusion
|
Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system. | $1M / Series A / May 31, 2020 | |
nanoGriptech
|
NanoGriptech has developed a nature-inspired microfiber based adhesive that functions in the same way a gecko’s feet stick to surfaces. As a dry, durable, residue-free, and customizable adhesive, nanoGriptech’s product provides a superior alternative to reusable adhesives currently being used in a large variety of industries such as clothing,sports, automotive, product design, and medical devices.The company has successfully engaged in partnerships with several multinational corporations across these industries and just started its first small volume sale in high friction/grip clothing material market. | $6M / Venture - Series Unknown / Mar 12, 2020 | |
|
nanoGriptech
|
NanoGriptech has developed a nature-inspired microfiber based adhesive that functions in the same way a gecko’s feet stick to surfaces. As a dry, durable, residue-free, and customizable adhesive, nanoGriptech’s product provides a superior alternative to reusable adhesives currently being used in a large variety of industries such as clothing,sports, automotive, product design, and medical devices.The company has successfully engaged in partnerships with several multinational corporations across these industries and just started its first small volume sale in high friction/grip clothing material market. | $1.7M / Dec 12, 2018 |
Co-Investors
We are the venture capital arm of the renowned R&D consortium – the Industrial Technology Research Institute (ITRI). Since our creation in 1979, we have invested over US$400 million across virtually all stages, sectors, and timezones. Companies we have nurtured have gone on to define entire industries, and boast a combined market cap of wellover US$200 billion. Since its inception, ITIC has been instrumental in leading Taiwan's initial ventures into technology-based businesses, such as integrated circuits, automation, opto-electronic display, etc. ITIC is an original shareholder of some industry leaders such as UMC, Taiwan Mask Corp., Acer Display Technologies, Inc.(renamed as AU Optronics Corp.).
ITIC: Industrial Technology Investment Corporation Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Hans Tai
President
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Hans Tai invest in?
Hans Tai invests primarily in Medical, Marketing and Industrial startups, most often at Funding Round and Series A stage. Most of the 4 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Hans Tai?
Public channels for Hans Tai include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Hans Tai last invest?
The most recent investment recorded for Hans Tai closed in May 2020. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
